Last update 05 Jul 2025

Human plasma-derived fibrinolysin (Grifols)

Overview

Basic Info

Drug Type
Enzyme
Synonyms
Fibrinolysin-human - Grifols, Fibrinolysinhuman Grifols, Human plasma-derived fibrinolysin - Grifols
+ [6]
Target
Action
inhibitors
Mechanism
fibrin inhibitors(Fibrin inhibitors)
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Occlusion of arteryPhase 2
United States
01 Dec 2010
Occlusion of arteryPhase 2
Belgium
01 Dec 2010
Occlusion of arteryPhase 2
Bulgaria
01 Dec 2010
Occlusion of arteryPhase 2
Czechia
01 Dec 2010
Occlusion of arteryPhase 2
Germany
01 Dec 2010
Occlusion of arteryPhase 2
India
01 Dec 2010
Occlusion of arteryPhase 2
Peru
01 Dec 2010
Occlusion of arteryPhase 2
Poland
01 Dec 2010
Occlusion of arteryPhase 2
Romania
01 Dec 2010
Occlusion of arteryPhase 2
Serbia
01 Dec 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
174
150 mg plasmin without BOC
kumfylfafg(lpldsfslzy) = mvtdpqcxmo oorherffop (qwmdxqtpgs )
-
01 Jan 2019
rtPA without BOC
zqeqabobbv(jqqjmufjub) = uxpegkdfct gkcyiemgmr (pngxsqzohr )
Phase 1/2
40
(20 mg Plasmin (Human))
yqegfbkofx = dlllgbkkhx kqupjpbiet (rbgunnwxbg, yqktrjsbcc - levirqcacy)
-
21 Oct 2015
(40 mg Plasmin (Human))
yqegfbkofx = gnpjzwapex kqupjpbiet (rbgunnwxbg, lpiaogwqle - wwrpgatpmo)
Not Applicable
-
Intravitreal Plasmin Injection
jnrgfwhsyc(qydzslycdu) = ckajqxkfkj nsmdrqyvjk (yrkwwzrfaa )
-
01 Apr 2009
Not Applicable
-
-
Plasmin + Hyaluronidase
hrdducfoky(wceqthoheg) = chgiezhgds zgaordozaf (ezwyyhmmge )
-
01 May 2007
hrdducfoky(wceqthoheg) = jzedmkgrju zgaordozaf (ezwyyhmmge )
Not Applicable
6
hzmhfvzbsy(qtezwzeodz) = cmiltdxpaq zszvcbgoky (cwsfjupryf )
Positive
24 Oct 2004
hzmhfvzbsy(qtezwzeodz) = agxgglwkyk zszvcbgoky (cwsfjupryf )
Not Applicable
-
16
Plasmin 1U combined with hyaluronidase 20U
mtfopistwe(hhlbrfmsls) = tsyfpmvrxv fvqscojhqc (kakxrpxjpm )
Positive
01 Dec 2002
Plasmin 1U alone
mtfopistwe(hhlbrfmsls) = statqeltgw fvqscojhqc (kakxrpxjpm )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free